Spironolactone ameliorates the cardiovascular toxicity induced by concomitant trastuzumab and thoracic radiotherapy


Yavas G., Celik E., Yavas C., Elsurer C., Afsar R.

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, vol.22, no.4, pp.295-302, 2017 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 4
  • Publication Date: 2017
  • Doi Number: 10.1016/j.rpor.2017.01.004
  • Journal Name: REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY
  • Journal Indexes: Emerging Sources Citation Index, Scopus
  • Page Numbers: pp.295-302

Abstract

Aim: We aimed to evaluate impact of spironolactone (S) on cardiovascular toxicity of concomitant use of radiotherapy (RT) and trastuzumab (T).